Skip to main content

      Digital transfomration for the life sciences sector

      The life sciences sector is working on improving operations and creating new value by transforming digitally, in a highly regulated sector.

      With life sciences technology leaders racing to make the most of advanced technologies, but siloed, decentralised teams and historical underinvestment in data management are limiting the benefits.

      Our research finds there should be a balance between keeping up, and applying a strategic approach to extracting genuine value from tech. It is essential to navigate the hype using evidence-based decisions, find solutions that are resilient, and scale new tools such as AI safely and responsibly.

      Read the full report to explore more insights and KPMG life sciences technology specialist perspectives on the findings, and to obtain actionable recommendations for addressing life sciences organisation technology challenges.

      Life science

      KPMG global tech report: Life sciences insights

      Beyond the hype: Balancing speed, security and value.


      Survey participants

      123

      life sciences technology leaders

      26

      key markets

      $10B+

      in revenues (USD) for the majority of organisations



      Key findings for life sciences leaders

      Only 59% of life sciences respondents say their tech investment decision-making processes usually result in sound decisions that lead to valuable outcomes.

      Life sciences leads all of the eight industries surveyed in prioritising and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery.

      More than one-third of life sciences respondents say their organisations are using AI at scale and are achieving returns on investment.

      61% of life sciences respondents worry that cyber security is frequently treated as a box-ticking exercise in staff training and isn’t embedded as extensively as it could be.



      About KPMG's global tech
      report for life sciences

      The report explores the perspectives of 123 life sciences technology leaders from around the world. With valuable insights into how life sciences organisations are navigating the complexities of digital transformation and covers topics that include technology investment decision making, data, AI and cyber security.

      AI has increased the speed and volume of R&D activities in life sciences, which is likely to lead to new therapies being developed faster and more inexpensively in the future.

      Dr. Jayne Goble

      Partner, IoT OT Cyber Security Services

      KPMG UK



      Download report

      KPMG global tech report 2024: Life sciences insights

      Beyond the hype: Balancing speed, security and value.

      Life science

      KPMG global tech report: Life sciences insights

      Beyond the hype: Balancing speed, security and value.


      Connect with us



      Related insights and services

      Read insights from 2,450 tech professionals across 26 countries, including Australia, with strategies to maximise technology ROI.

      Technology Advisory

      KPMG can help organisations align their technology capabilities with their strategic and operational objectives.

      Technology Advisory

      Life Sciences

      KPMG's Life Sciences industry practice advises businesses from biotechnology startups to large multinational pharmaceutical companies.

      Life Sciences